| Joseph G Sramek, MD | |
|
200 Commons Way Ste B, Kalispell, MT 59901-1915 | |
| (406) 752-5170 | |
| (406) 752-5210 |
| Full Name | Joseph G Sramek |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 30 Years |
| Location | 200 Commons Way Ste B, Kalispell, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891763439 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 24371 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kalispell Regional Medical Center | Kalispell, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kalispell Regional Medical Center Inc | 5294644381 | 354 |
News Archive
Lighthouse1, an industry leader in consumer-driven healthcare (CDH) software solutions, today announced a partnership with TSYS Healthcare to provide an integrated end-to-end healthcare payment solution. The partnership brings another fully integrated payment solution to CDH administrators using the Lighthouse1 OnDemand™ platform.
Since its discovery as a protein that gets specifically released in response to brain injury, ciliary neurotrophic factor (CNTF) has prompted much interest as a potential therapeutic agent.
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage and ingredient supply industries, announced today that it has been notified by the Flavor and Extract Manufacturers Association (FEMA) that its sucrose enhancer, S6973, has been determined to be Generally Recognized As Safe (GRAS) under the provisions of the Federal Food, Drug and Cosmetic Act, administered by the United States Food and Drug Administration (FDA).
When cells divide, the proper balance between the four DNA building blocks is required in order for the DNA to be copied without the introduction of potentially harmful mutations. Researchers at Umea University in Sweden have now shown a connection between levels of DNA building blocks - dNTPs - and colon cancer. This discovery has been published in the Proceedings of the National Academy of Sciences.
› Verified 9 days ago
| Entity Name | Kalispell Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235333139 PECOS PAC ID: 5294644381 Enrollment ID: O20031122000142 |
News Archive
Lighthouse1, an industry leader in consumer-driven healthcare (CDH) software solutions, today announced a partnership with TSYS Healthcare to provide an integrated end-to-end healthcare payment solution. The partnership brings another fully integrated payment solution to CDH administrators using the Lighthouse1 OnDemand™ platform.
Since its discovery as a protein that gets specifically released in response to brain injury, ciliary neurotrophic factor (CNTF) has prompted much interest as a potential therapeutic agent.
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage and ingredient supply industries, announced today that it has been notified by the Flavor and Extract Manufacturers Association (FEMA) that its sucrose enhancer, S6973, has been determined to be Generally Recognized As Safe (GRAS) under the provisions of the Federal Food, Drug and Cosmetic Act, administered by the United States Food and Drug Administration (FDA).
When cells divide, the proper balance between the four DNA building blocks is required in order for the DNA to be copied without the introduction of potentially harmful mutations. Researchers at Umea University in Sweden have now shown a connection between levels of DNA building blocks - dNTPs - and colon cancer. This discovery has been published in the Proceedings of the National Academy of Sciences.
› Verified 9 days ago
| Entity Name | St. Peter's Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205025145 PECOS PAC ID: 7911814926 Enrollment ID: O20031204001245 |
News Archive
Lighthouse1, an industry leader in consumer-driven healthcare (CDH) software solutions, today announced a partnership with TSYS Healthcare to provide an integrated end-to-end healthcare payment solution. The partnership brings another fully integrated payment solution to CDH administrators using the Lighthouse1 OnDemand™ platform.
Since its discovery as a protein that gets specifically released in response to brain injury, ciliary neurotrophic factor (CNTF) has prompted much interest as a potential therapeutic agent.
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage and ingredient supply industries, announced today that it has been notified by the Flavor and Extract Manufacturers Association (FEMA) that its sucrose enhancer, S6973, has been determined to be Generally Recognized As Safe (GRAS) under the provisions of the Federal Food, Drug and Cosmetic Act, administered by the United States Food and Drug Administration (FDA).
When cells divide, the proper balance between the four DNA building blocks is required in order for the DNA to be copied without the introduction of potentially harmful mutations. Researchers at Umea University in Sweden have now shown a connection between levels of DNA building blocks - dNTPs - and colon cancer. This discovery has been published in the Proceedings of the National Academy of Sciences.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph G Sramek, MD 200 Commons Way Ste B, Kalispell, MT 59901-1915 Ph: (406) 752-5170 | Joseph G Sramek, MD 200 Commons Way Ste B, Kalispell, MT 59901-1915 Ph: (406) 752-5170 |
News Archive
Lighthouse1, an industry leader in consumer-driven healthcare (CDH) software solutions, today announced a partnership with TSYS Healthcare to provide an integrated end-to-end healthcare payment solution. The partnership brings another fully integrated payment solution to CDH administrators using the Lighthouse1 OnDemand™ platform.
Since its discovery as a protein that gets specifically released in response to brain injury, ciliary neurotrophic factor (CNTF) has prompted much interest as a potential therapeutic agent.
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage and ingredient supply industries, announced today that it has been notified by the Flavor and Extract Manufacturers Association (FEMA) that its sucrose enhancer, S6973, has been determined to be Generally Recognized As Safe (GRAS) under the provisions of the Federal Food, Drug and Cosmetic Act, administered by the United States Food and Drug Administration (FDA).
When cells divide, the proper balance between the four DNA building blocks is required in order for the DNA to be copied without the introduction of potentially harmful mutations. Researchers at Umea University in Sweden have now shown a connection between levels of DNA building blocks - dNTPs - and colon cancer. This discovery has been published in the Proceedings of the National Academy of Sciences.
› Verified 9 days ago
Douglas L Griffith, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1297 Burns Way, Suite 4, Kalispell, MT 59901 Phone: 406-752-5170 Fax: 406-752-5120 | |
Dr. Stephen S. Campbell, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Commons Way Ste B, Kalispell, MT 59901 Phone: 406-752-5095 | |
Joshua Lee Ryan Krass, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Commons Way Ste B, Kalispell, MT 59901 Phone: 406-752-5170 Fax: 406-752-5210 | |
Kelly Suzanne Schmidt, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Commons Way Ste B, Kalispell, MT 59901 Phone: 406-752-5170 Fax: 406-752-5210 | |
Thomas Origitano, MD PHD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Commons Way Ste B, Kalispell, MT 59901 Phone: 406-752-5170 | |
Richard C Dewey, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1297 Burns Way, Suite 4, Kalispell, MT 59901 Phone: 406-752-5170 |